logo
logo

Microtransponder Raises $53M, Appoints New Ceo

Jun 20, 2022about 3 years ago

Amount Raised

$53 Million

Austin

Description

MicroTransponder®, Inc. closed an oversubscribed $53 million Series E funding round led by US Venture Partners (USVP), a multi-stage investment firm. GPG Ventures and Exceller Hunt Ventures return as existing investors alongside new venture investors that include Osage University Partners, Action Potential Venture Capital and The Vertical Group. The company plans to use the funds to commercialize the Vivistim® Paired VNSTM System and establish it as the recommended rehabilitation intervention for stroke survivors working to improve their quality of life through more hand and arm mobility.

Company Information

Company

Micro Transponder

Location

Austin, Texas, United States

About

The company plans to use the funds to commercialize the Vivistim® Paired VNS™ System and establish it as the recommended rehabilitation intervention for stroke survivors working to improve their quality of life through more hand and arm mobility. The company focuses on restoring independence and dignity for people suffering from neurological conditions that impair sensory and motor function. Vivistim is MicroTransponder's first FDA-approved use of its novel neuroplasticity-based medical device platform.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech